References
- Scheld WM, Koedel U, Nathan B, Pfister HW. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J Infect Dis 2002;186:S225–33.
- Sigurdardottir B, Bjornsson OM, Jonsdottir KE, Erlendsdottir H, Gudmundsson S. Acute bacterial meningitis in adults: a 20-year overview. Arch Intern Med 1997;157: 425–30.
- van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351:1849–59.
- Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, Hadler JL, et al. Bacterial meningitis in the United States, 1998–2007. N Engl J Med 2011;364: 2016–25.
- van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. N Engl J Med 2006;354:44–53.
- Berndsen MR, Erlendsdóttir H, Gottfredsson M. Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study. Clin Microbiol Infect 2012;18:918–23.
- Gottfredsson M, Diggle MA, Lawrie DI, Erlensdóttir H, Hardardottir H, Kristinsson KG, et al. Neisseria meningitidis sequence type and risk for death, Iceland. Emerg Infect Dis 2006;12:1066–73.
- Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine 2009;27:B51–63.
- Hussein AS, Shafran SD. Acute bacterial meningitis in adults: a 12-year review. Medicine (Baltimore) 2000; 79:360–8.
- Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997;337:970–6.
- Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS, et al. Acute bacterial meningitis in adults—a review of 493 episodes. N Engl J Med 1993; 328:21–8.
- McMillan DA, Lin CY, Aronin SI, Quagliarello VJ. Community-acquired bacterial meningitis in adults: categorization of causes and timing of death. Clin Infect Dis 2001; 33:969–75.
- Domingo P, Barquet N, Alvarez M, Coll P, Nava J, Garau J. Group B streptococcal meningitis in adults: report of twelve cases and review. Clin Infect Dis 1997;25:1180–7.
- Lepur D, Baršić B. Community-acquired bacterial meningitis in adults: antibiotic timing in disease course and outcome. Infection 2007;35:225–31.
- Køster-Rasmussen R, Korshin A, Meyer CN. Antibiotic treatment delay and outcome in acute bacterial meningitis. J Infect 2008;57:449–54.
- de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347: 1549–56.
- Jónsdóttir KE, Arn rsson VH, Laxdal Th, Jónsson B. Bacterial meningitis in Iceland 1960–1989. Nord Med 1990; 105:257–9.
- EpiNorth. Meningococcal disease epidemiology. The Norwegian Institute of Public Health; 2013. Available at: http://www.epinorth.org/eway/default.aspx?pid=230&trg = Area_5279&MainArea_5260 = 5279:0:15,2937:1:0:0:::0:0&Area_5279=5291:44530::1:5290:1:::0:0&diseaseid=23 (accessed 20 November 2013).
- Khwannimit B, Chayakul P, Geater A. Acute bacterial meningitis in adults: a 20 year review. Southeast Asian J Trop Med Public Health. 2004;35:886–92.
- Seib KL, Pigozzi E, Muzzi A, Gawthorne JA, Delany I, Jennings MP, et al. A novel epigenetic regulator associated with the hypervirulent Neisseria meningitidis clonal complex 41/44. FASEB J 2011;25:3622–33.
- Hedberg ST, Törös B, Fredlund H, Olcén P, Mölling P. Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden, 2000 to 2010. Euro Surveill 2011;16:8–14.
- McIntyre PB, O’Brien KL, Greenwood B, van de Beek D. Effect of vaccines on bacterial meningitis worldwide. Lancet 2012;380:1703–11.
- Balmer P, Borrow R, Miller E. Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol 2002;51: 717–22.